Episode Details

Back to Episodes
Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals

Pharmaceutical Executive Daily: Pathos AI Enters Two lIcensing Deals

Published 3 months, 2 weeks ago
Description
In today's Pharmaceutical Executive Daily, Pathos AI signs licensing deals with Alphamab Oncology and AstraZeneca while Curium agrees to acquire Lantheus for up to $8 billion, Sandoz agrees to a $450 million settlement with 43 U.S. states over generic drug antitrust claims, and a new analysis argues real-time data analytics are essential to managing the growing data burden in clinical trials.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us